Victory Capital Management Inc Point Biopharma Global Inc. Transaction History

Victory Capital Management Inc

  • $95.8 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022
SELL
$5.6 - $9.5 $431 - $731
-77 Reduced 0.67%
11,395 $78,000
Q1 2022

May 04, 2022
SELL
$5.46 - $8.13 $1,790 - $2,666
-328 Reduced 2.78%
11,472 $98,000
Q4 2021

Feb 07, 2022
BUY
$4.83 - $9.75 $6,066 - $12,246
1,256 Added 11.91%
11,800 $66,000
Q3 2021

Nov 02, 2021
BUY
$7.42 - $11.26 $78,236 - $118,725
10,544 New
10,544 $81,000

Others Institutions Holding PNT

# of Institutions
1
Shares Held
20K
Call Options Held
0
Put Options Held
0
View Full List

About POINT Biopharma Global Inc.

PNT Quotes by TradingView
  • Ticker PNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,025,000
  • Description
  • POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...
More about PNT
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email